TY - JOUR
T1 - In vitro characterization of methotrexate loaded poly(lactic-co-glycolic) acid microspheres and antitumor efficacy in Sarcoma-180 mice bearing tumor
AU - Singh, U. V.
AU - Udupa, N.
PY - 1997/6
Y1 - 1997/6
N2 - Methotrexate (MTX) loaded poly (lactic-co-glycolic) acid (PLGA) microspheres were prepared by emulsion solvent evaporation technique. The mean diameter of the microspheres was affected by the type of emulsion stabilizer, polymer concentration, aqueous and organic phase volume and stirring speed. The in vitro release was triphasic and was dependent on copolymer composition and molecular weight of the polymer. Antitumor efficacy in Sarcoma-180 tumor bearing mice exhibited increased volume doubling time (18 ± 2.7 days) compared to plain subcutaneous injection of methotrexate (8 ± 0.7 days). Preliminary pharmacokinetic studies following subcutaneous administration of MTX loaded PLGA microspheres illustrated the controlled release of the drug. The studies demonstrated the feasibility of employing PLGA as an effective carrier for antineoplastic drug like methotrexate.
AB - Methotrexate (MTX) loaded poly (lactic-co-glycolic) acid (PLGA) microspheres were prepared by emulsion solvent evaporation technique. The mean diameter of the microspheres was affected by the type of emulsion stabilizer, polymer concentration, aqueous and organic phase volume and stirring speed. The in vitro release was triphasic and was dependent on copolymer composition and molecular weight of the polymer. Antitumor efficacy in Sarcoma-180 tumor bearing mice exhibited increased volume doubling time (18 ± 2.7 days) compared to plain subcutaneous injection of methotrexate (8 ± 0.7 days). Preliminary pharmacokinetic studies following subcutaneous administration of MTX loaded PLGA microspheres illustrated the controlled release of the drug. The studies demonstrated the feasibility of employing PLGA as an effective carrier for antineoplastic drug like methotrexate.
UR - http://www.scopus.com/inward/record.url?scp=0030925675&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030925675&partnerID=8YFLogxK
U2 - 10.1016/S0031-6865(97)00013-7
DO - 10.1016/S0031-6865(97)00013-7
M3 - Article
C2 - 9204775
AN - SCOPUS:0030925675
SN - 0031-6865
VL - 72
SP - 165
EP - 173
JO - Pharmaceutica Acta Helvetiae
JF - Pharmaceutica Acta Helvetiae
IS - 3
ER -